| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000049380 |
| Receipt No. | R000056123 |
| Scientific Title | Evaluation of combined effects about ingesting food containing amino acids and exercise on facial muscles and features : a randomized, placebo-controlled, double-blind study |
| Date of disclosure of the study information | 2022/10/31 |
| Last modified on | 2022/10/31 (Ver. 1) |
| Basic information | ||
| Public title | Evaluation of combined effects for middle aged female about ingesting food containing amino acids and exercise on facial muscles and features. | |
| Acronym | Evaluation of combined effects for middle aged female about ingesting food containing amino acids and exercise on facial muscles and features. | |
| Scientific Title | Evaluation of combined effects about ingesting food containing amino acids and exercise on facial muscles and features
: a randomized, placebo-controlled, double-blind study |
|
| Scientific Title:Acronym | Evaluation of combined effects about ingesting food containing amino acids and face exercise on facial muscles and features by RCT study | |
| Region |
|
|
| Condition | |||
| Condition | healthy adults | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | This study examines effects on facial muscles and facial shape and features in healthy middle aged female adults by ingest food containing amino acids and exercise on facial muscles. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Change in thickness of the central part and originating part of the zygomaticis major muscle. |
| Key secondary outcomes | Depth and angle of the laugh lines
Angle of the laugh lines from the nose 3D facial photography Skin elasticity |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 2 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | After daily exercise by facial equipment device, intake food (active) once a day for12 weeks. | ||
| Interventions/Control_2 | After daily exercise by facial equipment device, intake of food (placebo) once a day for 12 weeks
|
||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1) Japanese healthy female aged 40-54 years
2) Females who are concerned about sagging face and smile lines 3) Females with a BMI of 20-23.9 |
|||
| Key exclusion criteria | (1) Subjects who have a smoking habit.
(2) Subjects with a history of serious diseases such as heart, liver, kidneys. (3) Subjects who have 5 or more metal objects (bolts, silver teeth, etc.) on the upper jaw. (4) Subjects with a history of other serious diseases. (5) Subjects who is taking medication or under medical treatment. (6) Subjects who have undergone immunosuppression or other treatment within 3 months. (7) Subjects who may develop allergies related to the study. (8) Subjects with chronic skin diseases such as atopic dermatitis. (9) Subjects who have scars, warts, pimples, permanent makeup, burns, etc. on the face that affect the research target area. (10) Claustrophobic subjects. (11) Subjects receiving "hormone replacement therapy". (12) Subjects who have experience in aesthetic medicine that affect the research target area. (13) Subjects using supplements. (14) Subjects with irregular lifestyle habits such as eating, sleeping and skin care. (15) Subjects drinking heavily. (16) Subjects who can't keep the daily records. (17) Subjects who is planning to get pregnant during the test period after the day of informed consent or is currently pregnant and lactating. (18) Subjects who participate in other clinical trial. (19) Subjects whose family members work for companies related to the sale of beauty equipment and supplements. (20) Subjects judged by the physician to be unsuitable for this study. |
|||
| Target sample size | 30 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Ajinomoto Co., Inc. | ||||||
| Division name | Institute of Food Sciences and Technologies | ||||||
| Zip code | 210-8681 | ||||||
| Address | 1-1, Suzuki-cho, Kawasaki-ku, Kawasaki-shi, Kanagawa, Japan | ||||||
| TEL | 080-1002-7371 | ||||||
| yuuji.suda.53c@asv.ajinomoto.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Ajinomoto Co., Inc. | ||||||
| Division name | Institute of Food Sciences and Technologies | ||||||
| Zip code | 210-8681 | ||||||
| Address | 1-1, Suzuki-cho, Kawasaki-ku, Kawasaki-shi, Kanagawa, Japan | ||||||
| TEL | 070-4017-9656 | ||||||
| Homepage URL | |||||||
| ikuko.sasahara.ve8@asv.ajinomoto.com | |||||||
| Sponsor | |
| Institute | KSO Co., Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Ajinomoto Co., Inc. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Aging Imaging laboratory, Inc.
YA-MAN Ltd. |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Ethics Committee of Ajinomoto Co., Ltd |
| Address | 1-15-1, Kyobashi, Chuo-ku, Tokyo |
| Tel | +81-3-5250-8134 |
| ajinomoto_irb@ajinomoto.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 株式会社ケイ・エス・オー(東京都)/KSO Co., Ltd. (Toky) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056123 |